Quantitative Systems Pharmacology (QSP) Summit Cambridge

Thursday, October 12th | Le Meridien Boston Cambridge

Jump to…

About the Event

The Quantitative Systems Pharmacology (QSP) Summit is a premier, free conference dedicated to fostering an active community of industry and academic participants interested in topics relevant to QSP. In its sixth year, the QSP Summit is a one-day event featuring talks from key industry and academic researchers, a poster session, and networking time with peers.

QSP Summit Promotional Graphic

Featured Speakers

Jane Bai, PhD - Expert Regulatory Scientist at the U.S. Food and Drug Administration

Rajat Desikan, PhD - Director of Quantitative Clinical Pharmacology at GSK

Jennifer Fretland, PhD - Senior Director of DMPK at EQRx

Irina Kareva, PhD - Associate Director at EMD Serono

Lyndsey Meyer, PhD - Researcher at Pfizer

Fereshteh Nazari, PhD - Translational PK/PD Modeler at Takeda

Alex Pellerin, PhD - Director at Seismic Therapeutic

Tianjing (Kiko) Ren, PhD - Postdoctoral Fellow at University at Buffalo and GSK

Peter Sorger, PhD - Otto Krayer Professor of Systems Pharmacology at Harvard Medical School

Weirong Wang, PhD - Senior Scientific Director at Janssen R&D, Johnson & Johnson

Agenda

View the agenda as a PDF >>

Start Time (ET)	Event
8:30 AM	Breakfast and registration
9:00 AM	Opening remarks
9:15 AM	Alex Pellerin, PhD Director at Seismic Therapeutic "Preclinical modeling of an IgG cleaving enzyme: A solution to a unique problem”
9:45 AM	Lyndsey Meyer, PhD Researcher at Pfizer “Developing a QSP model to interrogate mitochondrial dysfunction for applications in heart failure”
10:15 AM	Fereshteh Nazari, PhD Translational PK/PD Modeler at Takeda "A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development"
10:45 AM	Break and poster session
11:15 AM	Jane Bai, PhD Expert Regulatory Scientist at the U.S. Food and Drug Administration "Role of quantitative systems pharmacology in model informed drug development"
11:45 AM	Lightning Talks Two, ten-minute talks selected from abstract submissions Taylor Eggertsen, Graduate Research Assistant at the University of Virginia Narshini Gunputh, Intern at Takeda
12:05 PM	Lunch and poster session
1:00 PM	Weirong Wang, PhD Senior Scientific Director at Janssen "Exploring Immune Cell Dynamics with QSP Modeling: Case Studies in SLE and CRS"
1:30 PM	Jennifer Fretland, PhD Senior Director at EQRx "Application of Model-Informed Drug Development in Early Discovery"
2:00 PM	Break and poster session
2:30 PM	Rajat Desikan, PhD Director, Quantitative Clinical Pharmacology at GSK Tianjing (Kiko) Ren, PhD Postdoctoral Fellow at GSK and University of Buffalo "QSP modeling of chronic Hepatitis B infection decodes the mechanistic underpinnings of differential functional cure rates with standard-of-care therapies"
3:00 PM	Irina Kareva, PhD Associate Director at EMD Serono "Minimally Sufficient Experimental Design using Identifiability Analysis"
3:30 PM	Peter Sorger, PhD Otto Krayer Professor of Systems Pharmacology at Harvard Medical School "Multimodal tissue imaging and machine learning to advance precision medicine"
4:00 PM	Roundtable Discussion Fretland (EQRx), Kareva (EMD Serono), Meyer (Pfizer), Pellerin (Seismic Therapeutic), and Sorger (Harvard Medical School) Moderated by John Burke, PhD, Co-founder, President and CEO at Applied BioMath
5:00 PM	Closing remarks and poster awards
5:15 PM	QSP Summit concludes